We are live on
!
Find out more
PM
Parametrica Management Portfolio holdings
AUM
$128M
1-Year Est. Return
171.01%
This Fund
S&P 500
This Quarter
Est. Return
+18.2%
1 Year Est. Return
+171.01%
3 Year Est. Return
+584.08%
5 Year Est. Return
+696.69%
10 Year Est. Return
–
AUM
$60.9M
AUM Growth
+$1.5M
(+2.5%)
Cap. Flow
-$7.05M
Cap. Flow
% of AUM
-11.57%
Top 10 Holdings %
Top 10 Hldgs %
69.73%
Holding
37
New
7
Increased
10
Reduced
8
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$1.9M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.47M |
| 4 |
Iovance Biotherapeutics
IOVA
|
+$1.18M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$915K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Morningstar Wide Moat ETF
MOAT
|
+$4.57M |
| 2 |
Eli Lilly
LLY
|
+$2.81M |
| 3 |
Tesla
TSLA
|
+$2.59M |
| 4 |
Pinduoduo
PDD
|
+$1.92M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$1.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 33.95% |
| 2 | Technology | 27% |
| 3 | Consumer Discretionary | 14.93% |
| 4 | Miscellaneous | 11.62% |
| 5 | Healthcare | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Century Therapeutics
IPSC
$404M
| $92.4K | 0.15% |
27,840
| – | – |
|
27
Fate Therapeutics
FATE
$304M
| $69.1K | 0.11% |
18,472
| – | – |
|
|
LAC
28
Lithium Americas
LAC
$1.15B
| $67.6K | 0.11% |
+10,555
| New | +$78.6K |
|
29
Arbe Robotics
ARBE
$84.9M
| $53.3K | 0.09% |
24,578
-8,934
| -27% | -$18.1K |
|
30
Apple
AAPL
$4.59T
| – | – |
-5,300
| Closed | -$907K |
|
31
Alnylam Pharmaceuticals
ALNY
$31.7B
| – | – |
-3,221
| Closed | -$570K |
|
32
Applied Materials
AMAT
$383B
| – | – |
-9,800
| Closed | -$1.36M |
|
33
Amazon
AMZN
$2.76T
| – | – |
-4,795
| Closed | -$610K |
|
34
Match Group
MTCH
$9.46B
| – | – |
-16,600
| Closed | -$650K |
|
35
iShares Semiconductor ETF
SOXX
$42.8B
| – | – |
-4,800
| Closed | -$758K |
|
|
36
Tesla
TSLA
$1.4T
| – | – |
-10,332
| Closed | -$2.59M |
|
37
10x Genomics
TXG
$8.45B
| – | – |
-15,300
| Closed | -$631K |
|
Similar funds
CIS
CWM
NYU
FCU
TLM
RPG
OCM
FFG
Parametrica Management's Q4 2023 Portfolio in Review
As of Q4 2023, Parametrica Management held 37 positions worth $60.9M, up 2.5% from $59.4M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Parametrica Management withdrew a net $7.05M in Q4 2023, closing 8 positions and reducing 8 holdings. Its most notable exit was Tesla, an estimated $2.59M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 34% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Parametrica Management opened a new position in Nu Holdings worth $1.96M.
- Parametrica Management's largest Q4 2023 buy was Nu Holdings: 235,663 shares worth $1.96M.
- Parametrica Management added most to Alphabet (Google) Class A in Q4 2023, an estimated $1.9M increase.
- Parametrica Management's biggest Q4 2023 reduction was VanEck Morningstar Wide Moat ETF, cutting an estimated $4.57M.
- Parametrica Management fully exited Tesla in Q4 2023, selling an estimated $2.59M.
- Parametrica Management's ten largest holdings make up 70% of its $60.9M portfolio in Q4 2023.
- Parametrica Management opened 7 new positions and closed 8 in Q4 2023.
- Parametrica Management's portfolio value rose 2.5% quarter-over-quarter to $60.9M.
Based on Parametrica Management's 13F filing for Q4 2023, filed 2 Feb 2024.